本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

38.58
+1.143.04%
盘后38.580.00000.00%19:53 EDT
成交量:165.81万
成交额:6,283.31万
市值:71.73亿
市盈率:-10.78
高:38.68
开:37.41
低:36.92
收:37.44
数据加载中...
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities